Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers compared gut microbial profiles in obese children with non-alcoholic fatty liver disease (NAFLD), obese children without NAFLD, and healthy lean children. NAFLD is the most common cause of pediatric liver disease and is closely tied to obesity.
How was it studied?
Fecal samples underwent 16S rRNA gene microarray analysis, shotgun metagenomic sequencing, mass spectrometry based proteomics, and NMR spectroscopy for metabolite profiling. This combined phylogenetic, metagenomic, proteomic, and metabolomic approach let the authors link taxa to function.
What did they find?
Children with NAFLD had more abundant Gammaproteobacteria and Prevotella and significantly higher fecal ethanol levels, alongside altered short chain fatty acid patterns. Their gut microbiome and metaproteome showed increased capacity for energy production, with reduced carbohydrate and amino acid metabolism and diminished urea cycle and urea transport pathways.
Why it matters
The pediatric NAFLD gut microbiome favors alcohol production and energy harvesting over carbohydrate and amino acid processing. This metabolic shift may contribute to fatty liver disease pathogenesis in obese children.